<DOC>
	<DOCNO>NCT00527202</DOCNO>
	<brief_summary>Objectives : investigate analgesic effect safety intradermal botulinum toxin A injection treatment focal painful neuropathy ( eg , postherpetic neuralgia , nerve trauma )</brief_summary>
	<brief_title>Efficacy Study Botox Treat Neuropathic Pain</brief_title>
	<detailed_description>The study randomize , perform parallel group double blind versus saline include 30 patient . Botulinum toxin injection inject intradermally painful area ( one single injection ) follow method adapt used hyperhidrosis . The patient follow 6 month injection . Primary outcome self-reported pain patient diary . Secondary outcome neuropathic symptom , quality life , allodynia brush pressure , detection pain threshold , proportion responder , pain relief clinical global impression . Clinical assessment take place injection 1 month , 3 month 6 month .</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>daily pain least 6 month least moderate intensity clearly attribute nerve lesion limit area pain mechanical allodynia painful area contraindication BTXA formulation coagulation disorder another painful condition current major depression history drug alcohol abuse compensation claim litigation facial neuropathic pain</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2007</verification_date>
</DOC>